LoginSign Up
Serenity Bioworks

Serenity Bioworks

Immune-compatible gene therapy company.

Serenity is developing an immunomodulatory platform called CargoTek. Their initial focus is to improve AAV gene therapy for monogenic diseases like hemophilia A, inherited retinal diseases and neurodegenerative diseases.

Funding

In June 2018, Serenity Bioworks closed their Seed round. The amount raised was not disclosed. The round was led by SOSV.

Timeline

People

Name
Role
Related Golden topics

Cody Shirriff

Founder

Spencer Berg

Founder

Further reading

Title
Author
Link
Type

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

References